Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Meet Our Editorial Board Member free to download

Volume:17   Issue:1
Pp: 1-1
G. S.W. Tsao
DOI: 10.2174/156800961701161202195944

Preface: Scientific Premise and Rigors in Scientific Research, Peer Review, Editing and Publishing free to download

Volume:17   Issue:1
Pp: 2-2
Ruiwen Zhang
DOI: 10.2174/156800961701161202200123

Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

Volume:17   Issue:1
Pp: 62-73
Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal and Jose Luis Passos-Coelho
DOI: 10.2174/1568009616666161025114914

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

Volume:17   Issue:1
Pp: 89-97
Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu and Jun Zhang
DOI: 10.2174/1568009616666161013101657